Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
Peer-reviewed journal Clinical Chemistry published the first head-to-head study comparing GraftAssure™ to industry-leading competitorGraftAssure’s industry-leading reference change value (time-point...
-
HOUSTON, June 16, 2026 (GLOBE NEWSWIRE) -- Devon Energy Corp. (NYSE: DVN) today announced Clay Gaspar, President and CEO will participate in a fireside chat at the J.P. Morgan Energy, Power,...
-
Opus Genetics Highlights Five Gene Therapy Programs Targeting Significant Unmet Need in Patients with Inherited Retinal Diseases
-
RALEIGH, N.C., June 16, 2026 (GLOBE NEWSWIRE) -- Highwoods Properties, Inc. (NYSE:HIW) will release its second quarter 2026 results on Tuesday, July 28th, after the market closes. A conference call...
-
Oportun Appoints Sean Rowles as Chief Risk Officer
-
NEW YORK, June 16, 2026 (GLOBE NEWSWIRE) -- TheDoseReport.com announces the release of its comprehensive Medvi Review, focusing on telehealth GLP-1 programs for weight management. Considering GLP-1...
-
Collaboration aimed at integrating Scanon.ai’s current privacy-first artificial intelligence and computer vision capabilities into Myseum.AI’s flagship Picture Party platform Final agreement would...
-
The collaboration brings clinical and behavioural weight management together, offering UK members a more integrated path to sustainable weight loss. CheqUp becomes the dedicated partner for...
-
Mechelen, Belgium; June 16, 2026, 22.01 CET; regulated information Within the framework of the repurchase program announced on June 9, 2026, Lakefront Biotherapeutics NV (Euronext & NASDAQ: LKFT)...
-
Mechelen, België; 16 juni 2026, 22.01 CET; gereglementeerde informatie In het kader van het op 9 juni 2026 aangekondigde inkoopprogramma maakt Lakefront Biotherapeutics NV (Euronext & NASDAQ:...